- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: CKD-497 placebo
Total 54941 results
-
Chong Kun Dang PharmaceuticalCompletedRespiratory InfectionKorea, Republic of
-
Chong Kun Dang PharmaceuticalRecruitingAndrogenetic AlopeciaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHealthy SubjectsUnited Kingdom
-
Peking UniversityKAEDINot yet recruitingGastric Cancer | Pancreatic Cancer | Solid TumorChina
-
jianming xuKAEDIRecruitingGastric Cancer | Pancreatic Cancer | Solid TumorChina
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of
-
Chong Kun Dang PharmaceuticalRecruitingPrimary HypercholesterolemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertensive Patients With DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedDyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedDyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedDyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedBenign Prostatic HyperplasiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalUnknownType2 DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedEfficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 DiabetesType2 DiabetesKorea, Republic of
-
Universidade Federal FluminenseCompletedHemodialysis | Chronic Kidney Disease | Non-dialysis PatientsBrazil
-
Chong Kun Dang PharmaceuticalRecruitingEfficacy and Safety of CKD-501 Added to D150 Plus D745 25mg Therapy in Patients With Type 2 DiabetesType2 DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHealthyKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension | DyslipidemiasKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedAlopeciaKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownA Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial FibrillationAtrial FibrillationKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType 2 Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedAlopeciaKorea, Republic of
-
Chong Kun Dang PharmaceuticalSeoul National University Bundang HospitalCompletedHealthyKorea, Republic of
-
HeNan Sincere Biotech Co., LtdCompleted
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType 2 DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownType2 Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownOcular Hypertension | Primary Open-angle GlaucomaKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknown
-
Brii Biosciences LimitedCompleted
-
Hartford HospitalYale UniversityActive, not recruiting
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Dana-Farber Cancer InstituteCompletedMultiple MyelomaUnited States
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType 2 DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedDyslipidemiasKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType 2 DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType2 Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension | HyperlipidemiasKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
Chong Kun Dang PharmaceuticalCompletedHypertension | DyslipidemiasKorea, Republic of